Pages that link to "Q35675384"
Jump to navigation
Jump to search
The following pages link to Circulating micro‐RNA expression profiles in early stage nonsmall cell lung cancer (Q35675384):
Displaying 50 items.
- Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies (Q24289207) (← links)
- New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies (Q26748881) (← links)
- Appraising MicroRNA-155 as a Noninvasive Diagnostic Biomarker for Cancer Detection: A Meta-Analysis (Q26772056) (← links)
- Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays (Q26777992) (← links)
- Current State of Circulating MicroRNAs as Cancer Biomarkers (Q26796328) (← links)
- Dysregulation of the Met pathway in non-small cell lung cancer: implications for drug targeting and resistance (Q26799900) (← links)
- Non-coding RNAs in lung cancer (Q26866521) (← links)
- Can microRNAs improve the management of lung cancer patients? A clinician's perspective (Q26999304) (← links)
- The miR-17/92 cluster: a comprehensive update on its genomics, genetics, functions and increasingly important and numerous roles in health and disease (Q27015587) (← links)
- Methodological challenges in utilizing miRNAs as circulating biomarkers (Q27027950) (← links)
- Circulating microRNAs: potential biomarkers for common malignancies (Q28081347) (← links)
- TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness (Q33592822) (← links)
- Exosomal microRNA in plasma as a non-invasive biomarker for the recurrence of non-small cell lung cancer (Q33598531) (← links)
- The effect of circulating miR-223 on surveillance of different cancers: a meta-analysis (Q33879198) (← links)
- Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse (Q33910168) (← links)
- MicroRNAs as lung cancer biomarkers (Q34031213) (← links)
- Cancer affects microRNA expression, release, and function in cardiac and skeletal muscle (Q34052685) (← links)
- Global population-specific variation in miRNA associated with cancer risk and clinical biomarkers (Q34155182) (← links)
- MicroRNAs As Biomarkers For Clinical Features Of Lung Cancer (Q34158964) (← links)
- Integrative analysis in oral squamous cell carcinoma reveals DNA copy number-associated miRNAs dysregulating target genes (Q34217210) (← links)
- Standardization of sample collection, isolation and analysis methods in extracellular vesicle research (Q34369038) (← links)
- MicroRNA expression profiles of whole blood in lung adenocarcinoma (Q34430694) (← links)
- Serum microRNA-155 as a potential biomarker to track disease in breast cancer (Q34447755) (← links)
- Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. (Q34559564) (← links)
- What makes a blood cell based miRNA expression pattern disease specific?--a miRNome analysis of blood cell subsets in lung cancer patients and healthy controls (Q34619416) (← links)
- The functional significance of microRNA-29c in patients with colorectal cancer: a potential circulating biomarker for predicting early relapse. (Q34806020) (← links)
- Comparisons of microRNA patterns in plasma before and after tumor removal reveal new biomarkers of lung squamous cell carcinoma (Q35018941) (← links)
- A genetic polymorphism in pre-miR-27a confers clinical outcome of non-small cell lung cancer in a Chinese population (Q35040261) (← links)
- Expression of miR-29c, miR-93, and miR-429 as potential biomarkers for detection of early stage non-small lung cancer (Q35093548) (← links)
- Prognostic and predictive biomarkers in early stage NSCLC: CTCs and serum/plasma markers (Q35200656) (← links)
- Evaluation of extraction kits and RT-qPCR systems adapted to high-throughput platform for circulating miRNAs (Q35210574) (← links)
- miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis. (Q35238507) (← links)
- The non-coding RNAs of the H19-IGF2 imprinted loci: a focus on biological roles and therapeutic potential in Lung Cancer (Q35425128) (← links)
- Technical factors involved in the measurement of circulating microRNA biomarkers for the detection of colorectal neoplasia (Q35432299) (← links)
- Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression (Q35562364) (← links)
- Circulating MicroRNAs as Non-Invasive Biomarkers for Early Detection of Non-Small-Cell Lung Cancer (Q35597752) (← links)
- Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer (Q35623347) (← links)
- MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells (Q35657534) (← links)
- Prognostic Value and Clinicopathology Significance of MicroRNA-200c Expression in Cancer: A Meta-Analysis (Q35675544) (← links)
- The Value of MicroRNA-155 as a Prognostic Factor for Survival in Non-Small Cell Lung Cancer: A Meta-Analysis (Q35760211) (← links)
- Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study (Q35806035) (← links)
- Analysis of Circulating MicroRNAs In Vivo following Administration of Dexamethasone and Adrenocorticotropin (Q35806449) (← links)
- Circulating microRNAs in esophageal squamous cell carcinoma: association with locoregional staging and survival. (Q35870720) (← links)
- Circulating microRNAs: next-generation biomarkers for early lung cancer detection (Q35883222) (← links)
- Applications of MicroRNAs in the Diagnosis and Prognosis of Lung Cancer (Q35970795) (← links)
- Circulating TGF-β1-Regulated miRNAs and the Risk of Rapid Progression to ESRD in Type 1 Diabetes (Q35973844) (← links)
- Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer (Q35993714) (← links)
- An integrated genome-wide approach to discover deregulated microRNAs in non-small cell lung cancer: Clinical significance of miR-23b-3p deregulation. (Q36002695) (← links)
- RBMMMDA: predicting multiple types of disease-microRNA associations (Q36034189) (← links)
- A serum circulating miRNA diagnostic test to identify asymptomatic high-risk individuals with early stage lung cancer (Q36038792) (← links)